NUVBNUVATION BIO INC
CUSIP 67080N101 · common stock
5 tracked investors held NUVATION BIO INC (NUVB) at the end of Q3 2026, worth $22.2M in total. The largest holder was Stanley Druckenmiller, with 0.3% of its portfolio. Torray Funds opened a new position this quarter.
Holders · Q3 2026
5
New holders
1
Value held
$22.2M
Quarter-end price (est.)
$5.60
Investors holding NUVB · Q3 2026
| Investor | Weight | Shares | Value | Change |
|---|---|---|---|---|
| Stanley Druckenmiller Duquesne Family Office LLC | 0.28% | 2,269,900 | $12.7M | REDUCE-50.0% |
| David Abrams Abrams Capital Management, L.P. | 0.15% | 1,270,504 | $7.1M | HOLD |
| Torray Funds Torray Investment Partners LLC | 0.20% | 274,814 | $1.5M | NEW |
| Joel Greenblatt Gotham Asset Management, LLC | 0.00% | 115,480 | $646.7K | REDUCE-36.6% |
| David Einhorn DME Capital Management, LP | 0.01% | 34,995 | $196K | HOLD |
History
| Quarter | Holders | New | Sold out | Value held | Quarter-end price (est.) |
|---|---|---|---|---|---|
| Q3 2026 | 5 | 1 | 0 | $22.2M | $5.60 |
| Q2 2026 | 4 | 1 | 1 | $34.2M | $5.68 |
| Q1 2026 | 4 | 2 | 1 | $25.3M | $4.29 |
| Q4 2025 | 3 | 0 | 0 | $34.7M | $8.96 |
| Q1 2023 | 0 | 0 | 1 | $0 | — |
| Q4 2022 | 1 | 0 | 0 | $9.2M | $1.92 |
| Q3 2022 | 1 | 0 | 0 | $23.3M | $2.24 |
| Q2 2022 | 1 | 0 | 0 | $33.8M | $3.24 |
| Q1 2022 | 1 | 0 | 0 | $54.9M | $5.26 |
| Q4 2021 | 1 | 0 | 0 | $73M | $8.46 |
| Q3 2021 | 1 | 0 | 0 | $85.4M | $9.90 |
| Q2 2021 | 1 | 0 | 0 | $77.1M | $8.95 |
| Q1 2021 | 1 | 1 | 0 | $82.4M | $9.55 |